Coronary Artery Bypass Surgery With or Without Mitral Valve Annuloplasty in Moderate Functional Ischemic Mitral Regurgitation Final Results of the Randomized Ischemic Mitral Evaluation (RIME) Trial
Top Cited Papers
- 19 November 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Cell Metabolism
- Vol. 126 (21), 2502-+
- https://doi.org/10.1161/CIRCULATIONAHA.112.143818
Abstract
Background-The role of mitral valve repair (MVR) during coronary artery bypass grafting (CABG) in patients with moderate ischemic mitral regurgitation (MR) is uncertain. We conducted a randomized, controlled trial to determine whether repairing the mitral valve during CABG may improve functional capacity and left ventricular reverse remodeling compared with CABG alone. Methods and Results-Seventy-three patients referred for CABG with moderate ischemic MR and an ejection fraction >30% were randomized to receive CABG plus MVR (34 patients) or CABG only (39 patients). The study was stopped early after review of interim data. At 1 year, there was a greater improvement in the primary end point of peak oxygen consumption in the CABG plus MVR group compared with the CABG group (3.3 mL/kg/min versus 0.8 mL/kg/min; P<0.001). There was also a greater improvement in the secondary end points in the CABG plus MVR group compared with the CABG group: left ventricular end-systolic volume index, MR volume, and plasma B-type natriuretic peptide reduction of 22.2 mL/m(2), 28.2 mL/beat, and 557.4 pg/mL, respectively versus 4.4 mL/m(2) (P=0.002), 9.2 mL/beat (P =0.001),and 394.7 pg/mL (P=0.003), respectively. Operation duration, blood transfusion, intubation duration, and hospital stay duration were greater in the CABG plus MVR group. Deaths at 30 days and 1 year were similar in both groups: 3% and 9%, respectively in the CABG plus MVR group, versus 3% (P=1.00) and 5% (P=0.66), respectively in the CABG group. Conclusions-Adding mitral annuloplasty to CABG in patients with moderate ischemic MR may improve functional capacity, left ventricular reverse remodeling, MR severity, and B-type natriuretic peptide levels, compared with CABG alone. The impact of these benefits on longer term clinical outcomes remains to be defined.Keywords
This publication has 40 references indexed in Scilit:
- Coronary Bypass Surgery with or without Surgical Ventricular ReconstructionNew England Journal of Medicine, 2009
- Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patientsJournal of Cardiovascular Medicine, 2009
- B‐Type Natriuretic Peptide (BNP) in Patients Undergoing Mitral Valve SurgeryJournal of Cardiac Surgery, 2008
- Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitationEuropean Heart Journal, 2008
- Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonanceJournal of Cardiovascular Magnetic Resonance, 2008
- Mild or Moderate Ischemic Mitral Regurgitation in Patients Undergoing Off-Pump Coronary Artery Bypass GraftingJournal of Cardiac Surgery, 2007
- Assessment of Functional Capacity in Clinical and Research SettingsCirculation, 2007
- Mitral regurgitation progression following isolated coronary artery bypass surgery: frequency, risk factors, and potential prevention strategiesEuropean Journal of Cardio-Thoracic Surgery, 2006
- The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacementEuropean Journal of Cardio-Thoracic Surgery, 1995
- Cardiopulmonary exercise testing for evaluation of chronic cardiac failureThe American Journal of Cardiology, 1985